Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Amarin - 32 Year Stock Price History | AMRN

Historical daily share price chart and data for Amarin since 1993 adjusted for splits and dividends. The latest closing stock price for Amarin as of August 19, 2025 is 15.82.
  • The all-time high Amarin stock closing price was 27500.00 on July 09, 1993.
  • The Amarin 52-week high stock price is 17.49, which is 10.6% above the current share price.
  • The Amarin 52-week low stock price is 7.08, which is 55.2% below the current share price.
  • The average Amarin stock price for the last 52 weeks is 11.66.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Amarin Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 11.9848 10.4720 17.3300 8.0020 15.8200 63.09%
2024 15.5530 17.7840 27.0000 8.8720 9.7000 -44.25%
2023 24.4838 23.8000 43.8000 13.2000 17.4000 -28.10%
2022 39.8223 70.2000 74.6000 21.4000 24.2000 -64.09%
2021 103.0901 100.6000 176.0000 64.8000 67.4000 -31.08%
2020 170.3802 430.6000 430.6000 72.8000 97.8000 -77.19%
2019 364.1571 260.2000 482.4000 252.2000 428.8000 57.53%
2018 144.3048 84.8000 459.6000 49.0000 272.2000 239.40%
2017 66.3661 61.8000 85.8000 57.4000 80.2000 30.19%
2016 46.8516 36.2000 69.4000 25.4000 61.6000 62.96%
2015 40.1429 22.6000 58.0000 20.0000 37.8000 92.92%
2014 30.3917 39.2000 48.0000 16.6460 19.5940 -50.27%
2013 118.2469 162.0000 183.2000 28.0000 39.4000 -75.65%
2012 221.6366 141.0000 309.2000 127.0000 161.8000 8.01%
2011 214.0792 166.6000 390.0000 120.6000 149.8000 -8.67%
2010 53.0791 27.6000 169.8000 19.6000 164.0200 473.54%
2009 23.8716 13.6000 39.0020 10.4000 28.5980 101.39%
2008 38.1171 50.0000 71.7980 12.0000 14.2000 -72.69%
2007 200.1849 436.0000 756.0000 45.0000 52.0000 -88.60%
2006 522.9477 270.0000 748.0000 254.0000 456.0000 90.00%
2005 358.4254 524.0000 680.8000 212.0000 240.0000 -55.72%
2004 277.9263 308.0000 798.0000 106.0000 542.0000 75.97%
2003 580.3368 788.0000 962.0000 278.0000 308.0000 -61.40%
2002 1685.8640 3420.0000 4200.0000 552.0000 798.0000 -77.04%
2001 2692.2460 1100.0000 5594.0000 1000.0000 3475.0000 215.91%
2000 1204.0249 900.0000 1556.2500 750.0000 1100.0000 15.79%
1999 1428.2570 887.5000 2275.0000 825.0000 950.0000 33.33%
1998 2096.1660 6125.0000 6125.0000 200.0000 712.5000 -88.60%
1997 10031.1192 11625.0000 13250.0000 5875.0000 6250.0000 -46.24%
1996 17057.8657 18000.0000 22500.0000 11000.0000 11625.0000 -35.42%
1995 14767.8167 13500.0000 20000.0000 10000.0000 18000.0000 38.46%
1994 15496.5475 17500.0000 21000.0000 9625.0000 13000.0000 -25.71%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.328B $0.229B
Amarin Corporation plc is a commercial-stage pharmaceutical company focused on developing therapies, especially based on omega-3 fatty acid for treating cardiovascular diseases. The company's sole marketed drug, Vascepa (icosapent ethyl) is approved in the United States as an adjunct to diet for treating severe hypertriglyceridemia or elevated triglyceride levels. The FDA approved Vascepa to reduce cardiovascular risk in patients with persistent elevated triglycerides on statin therapy for LDL-C. The drug received approval for both indications in Europe under the tradename of Vazkepa. It has initiated various promotional activities and direct-to-consumer programs as well as expanded its salesforce to support promotion of Vascepa's expanded label. A generic version of Vascepa has been launched for elevated TG levels.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $246.683B 18.00
Amgen (AMGN) United States $159.113B 13.55
Gilead Sciences (GILD) United States $146.390B 15.24
Vertex Pharmaceuticals (VRTX) United States $100.187B 25.83
Bristol Myers Squibb (BMY) United States $98.393B 7.18
GSK (GSK) United Kingdom $80.733B 9.39
CSL (CSLLY) Australia $70.792B 0.00
Regeneron Pharmaceuticals (REGN) United States $60.602B 14.74
Alnylam Pharmaceuticals (ALNY) United States $60.071B 0.00
Argenex SE (ARGX) Netherlands $40.202B 70.71
Insmed (INSM) United States $26.889B 0.00
BioNTech SE (BNTX) Germany $26.780B 0.00
Royalty Pharma (RPRX) United States $20.994B 8.20
Biogen (BIIB) United States $20.359B 8.67
Incyte (INCY) United States $16.688B 21.26
Illumina (ILMN) United States $15.616B 24.42
Genmab (GNMSF) Denmark $15.349B 13.59
Genmab (GMAB) Denmark $15.282B 13.93
Ascendis Pharma (ASND) Denmark $11.913B 0.00
BioMarin Pharmaceutical (BMRN) United States $11.004B 15.53
QIAGEN (QGEN) Netherlands $10.934B 20.97
Moderna (MRNA) United States $10.859B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.313B 22.81
Exelixis (EXEL) United States $10.100B 18.21
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.987B 0.00
Exact Sciences (EXAS) United States $8.648B 0.00
Bio-Techne Corp (TECH) United States $8.602B 31.72
Halozyme Therapeutics (HALO) United States $8.185B 14.40
Roivant Sciences (ROIV) United Kingdom $7.995B 0.00
Anbio Biotechnology (NNNN) Germany $7.497B 0.00
Guardant Health (GH) United States $7.304B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.231B 38.58
Repligen (RGEN) United States $6.948B 75.77
Revolution Medicines (RVMD) United States $6.831B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.723B 24.56
Legend Biotech (LEGN) United States $6.715B 0.00
Rhythm Pharmaceuticals (RYTM) United States $6.455B 0.00
Avidity Biosciences (RNA) United States $5.663B 0.00
Axsome Therapeutics (AXSM) United States $5.554B 0.00
Nuvalent (NUVL) United States $5.384B 0.00
Abivax SA (ABVX) France $5.210B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.926B 0.00
Merus (MRUS) Netherlands $4.814B 0.00
Alkermes (ALKS) Ireland $4.763B 13.23
Cytokinetics (CYTK) United States $4.528B 0.00
TG Therapeutics (TGTX) United States $4.430B 75.46
Zealand Pharma (ZLDPF) Denmark $4.332B 4.28
Ascentage Pharma Group - (AAPG) China $4.313B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.213B 39.02
Krystal Biotech (KRYS) United States $4.167B 29.26
ADMA Biologics Inc (ADMA) United States $4.162B 30.07
Vaxcyte (PCVX) United States $4.119B 0.00
Arcellx (ACLX) United States $3.993B 0.00
PTC Therapeutics (PTCT) United States $3.939B 6.54
Zai Lab (ZLAB) United States $3.937B 0.00
Telix Pharmaceuticals (TLX) Australia $3.824B 0.00
Akero Therapeutics (AKRO) United States $3.807B 0.00
Protagonist Therapeutics (PTGX) United States $3.499B 80.36
MoonLake Immunotherapeutics (MLTX) Switzerland $3.382B 0.00
Apellis Pharmaceuticals (APLS) United States $3.370B 0.00
Metsera (MTSR) United States $3.317B 0.00
Mirum Pharmaceuticals (MIRM) United States $3.273B 0.00
Jyong Biotech (MENS) Taiwan $3.161B 0.00
Kymera Therapeutics (KYMR) United States $3.044B 0.00
Ligand Pharmaceuticals (LGND) United States $3.019B 0.00
Scholar Rock Holding (SRRK) United States $2.895B 0.00
Bavarian Nordic (BVNRY) Denmark $2.893B 15.29
Xenon Pharmaceuticals (XENE) Canada $2.881B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.827B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.806B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.746B 0.00
Viking Therapeutics (VKTX) United States $2.739B 0.00
Alvotech (ALVO) Luxembourg $2.620B 19.75
Immunovant (IMVT) United States $2.583B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.457B 828.75
Liquidia Technologies (LQDA) United States $2.334B 0.00
Tarsus Pharmaceuticals (TARS) United States $2.267B 0.00
Amicus Therapeutics (FOLD) United States $2.262B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.210B 0.00
Denali Therapeutics (DNLI) United States $2.165B 0.00
ImmunityBio (IBRX) United States $2.155B 0.00
IDEAYA Biosciences (IDYA) United States $2.108B 0.00
Agios Pharmaceuticals (AGIO) United States $2.104B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.094B 11.74
Celcuity (CELC) United States $2.088B 0.00
Disc Medicine (IRON) United States $2.023B 0.00
Sarepta Therapeutics (SRPT) United States $1.972B 0.00
Belite Bio (BLTE) United States $1.968B 0.00
ANI Pharmaceuticals (ANIP) United States $1.956B 17.53
CG Oncology (CGON) United States $1.949B 0.00
Mesoblast (MESO) Australia $1.938B 0.00
Adaptive Biotechnologies (ADPT) United States $1.913B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.891B 0.00
Vericel (VCEL) United States $1.825B 301.42
Certara (CERT) United States $1.770B 32.41
Apogee Therapeutics (APGE) United States $1.679B 0.00
Twist Bioscience (TWST) United States $1.665B 0.00
Beam Therapeutics (BEAM) United States $1.654B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.630B 0.00
Biohaven (BHVN) United States $1.613B 0.00
Celldex Therapeutics (CLDX) United States $1.595B 0.00
Travere Therapeutics (TVTX) United States $1.572B 0.00
Cidara Therapeutics (CDTX) United States $1.559B 0.00
Novavax (NVAX) United States $1.546B 4.18
WAVE Life Sciences (WVE) Singapore $1.513B 0.00
Janux Therapeutics (JANX) United States $1.484B 0.00
Viridian Therapeutics (VRDN) United States $1.454B 0.00
Edgewise Therapeutics (EWTX) United States $1.454B 0.00
Vera Therapeutics (VERA) United States $1.409B 0.00
NovoCure (NVCR) Jersey $1.349B 0.00
Cogent Biosciences (COGT) United States $1.339B 0.00
89BIO (ETNB) United States $1.335B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.326B 0.00
AbCellera Biologics (ABCL) Canada $1.282B 0.00
Dynavax Technologies (DVAX) United States $1.230B 52.45
CureVac (CVAC) Germany $1.225B 5.69
Pharvaris (PHVS) Netherlands $1.216B 0.00
MannKind (MNKD) United States $1.215B 36.00
GRAIL (GRAL) United States $1.133B 0.00
Pacira BioSciences (PCRX) United States $1.132B 11.99
Intellia Therapeutics (NTLA) United States $1.105B 0.00
Structure Therapeutics (GPCR) United States $1.083B 0.00
LENZ Therapeutics (LENZ) United States $1.073B 0.00
Arcus Biosciences (RCUS) United States $1.071B 0.00
MiMedx (MDXG) United States $1.064B 23.97
Zymeworks (ZYME) United States $1.060B 0.00
Stoke Therapeutics (STOK) United States $1.013B 21.75
CorMedix Inc (CRMD) United States $0.975B 17.41
Spyre Therapeutics (SYRE) United States $0.973B 0.00
Precigen (PGEN) United States $0.959B 0.00
Mineralys Therapeutics (MLYS) United States $0.959B 0.00
Sionna Therapeutics (SION) United States $0.948B 0.00
Praxis Precision Medicines (PRAX) United States $0.943B 0.00
Iovance Biotherapeutics (IOVA) United States $0.941B 0.00
Oric Pharmaceuticals (ORIC) United States $0.932B 0.00
Nuvation Bio (NUVB) United States $0.921B 0.00
Geron (GERN) United States $0.912B 0.00
Upstream Bio (UPB) United States $0.911B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.892B 0.00
Trevi Therapeutics (TRVI) United States $0.891B 0.00
Urogen Pharma (URGN) United States $0.875B 0.00
Immunome (IMNM) United States $0.872B 0.00
Pharming Group (PHAR) Netherlands $0.862B 0.00
UniQure (QURE) Netherlands $0.841B 0.00
Sana Biotechnology (SANA) United States $0.823B 0.00
NeoGenomics (NEO) United States $0.815B 0.00
Anavex Life Sciences (AVXL) United States $0.811B 0.00
Oculis Holding AG (OCS) Switzerland $0.784B 0.00
ArriVent BioPharma (AVBP) United States $0.779B 0.00
Pharming Group (PHGUF) Netherlands $0.778B 0.00
Tango Therapeutics (TNGX) United States $0.774B 0.00
Niagen Bioscience (NAGE) United States $0.768B 74.08
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.761B 0.00
BGM Group (BGM) China $0.759B 0.00
Nurix Therapeutics (NRIX) United States $0.752B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.736B 0.00
Dianthus Therapeutics (DNTH) United States $0.731B 0.00
Gyre Therapeutics (GYRE) United States $0.725B 150.60
Fortrea Holdings (FTRE) United States $0.716B 12.73
Mind Medicine (MindMed) (MNMD) United States $0.714B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.712B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.707B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.699B 0.00
Immatics (IMTX) Germany $0.679B 0.00
Arbutus Biopharma (ABUS) United States $0.669B 0.00
Zenas BioPharma (ZBIO) United States $0.667B 0.00
GH Research (GHRS) Ireland $0.653B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Bicara Therapeutics (BCAX) United States $0.628B 0.00
Kura Oncology (KURA) United States $0.624B 0.00
MeiraGTx Holdings (MGTX) United States $0.610B 0.00
Vir Biotechnology (VIR) United States $0.606B 0.00
Maze Therapeutics (MAZE) United States $0.590B 0.00
Keros Therapeutics (KROS) United States $0.589B 46.74
Castle Biosciences (CSTL) United States $0.577B 56.86
Terns Pharmaceuticals (TERN) United States $0.573B 0.00
Rezolute (RZLT) United States $0.563B 0.00
AnaptysBio (ANAB) United States $0.554B 0.00
Tyra Biosciences (TYRA) United States $0.544B 0.00
Palvella Therapeutics (PVLA) United States $0.536B 0.00
Opthea (OPT) Australia $0.525B 0.00
Arvinas (ARVN) United States $0.524B 0.00
Rapport Therapeutics (RAPP) United States $0.520B 0.00
Cytek Biosciences (CTKB) United States $0.514B 0.00
Myriad Genetics (MYGN) United States $0.513B 0.00
Kodiak Sciences (KOD) United States $0.501B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.497B 0.00
Emergent Biosolutions (EBS) United States $0.490B 4.01
Septerna (SEPN) United States $0.487B 0.00
Verastem (VSTM) United States $0.479B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.476B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.462B 0.00
Prothena (PRTA) Ireland $0.459B 0.00
ATyr Pharma (ATYR) United States $0.457B 0.00
Solid Biosciences (SLDB) United States $0.452B 0.00
ITeos Therapeutics (ITOS) United States $0.448B 0.00
Cullinan Therapeutics (CGEM) United States $0.448B 0.00
PureTech Health (PRTC) United States $0.448B 0.00
MBX Biosciences (MBX) United States $0.447B 0.00
Tectonic Therapeutic (TECX) United States $0.443B 0.00
Gossamer Bio (GOSS) United States $0.437B 0.00
Prime Medicine (PRME) United States $0.436B 0.00
Eton Pharmaceuticals (ETON) United States $0.434B 0.00
Erasca (ERAS) United States $0.431B 0.00
Inventiva S.A (IVA) France $0.426B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.422B 0.00
Kamada (KMDA) Israel $0.416B 21.29
Replimune (REPL) United States $0.412B 0.00
REGENXBIO (RGNX) United States $0.406B 0.00
Aura Biosciences (AURA) United States $0.398B 0.00
Absci (ABSI) United States $0.392B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.388B 0.00
XOMA Royalty (XOMA) United States $0.388B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.387B 0.00
Compass Therapeutics (CMPX) United States $0.376B 0.00
Olema Pharmaceuticals (OLMA) United States $0.373B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.358B 0.00
Fulcrum Therapeutics (FULC) United States $0.358B 0.00
Northwest Biotherapeutics (NWBO) United States $0.357B 0.00
Astria Therapeutics (ATXS) United States $0.356B 0.00
Abeona Therapeutics (ABEO) United States $0.351B 7.43
ADC Therapeutics SA (ADCT) Switzerland $0.350B 0.00
I-Mab (IMAB) United States $0.344B 0.00
Inhibrx Biosciences (INBX) United States $0.333B 0.00
CytomX Therapeutics (CTMX) United States $0.330B 3.57
Benitec Biopharma (BNTC) United States $0.330B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.314B 0.00
Candel Therapeutics (CADL) United States $0.305B 0.00
Bright Minds Biosciences (DRUG) United States $0.300B 0.00
DiaMedica Therapeutics (DMAC) United States $0.298B 0.00
Design Therapeutics (DSGN) United States $0.294B 0.00
Ocugen (OCGN) United States $0.292B 0.00
Cartesian Therapeutics (RNAC) United States $0.282B 0.00
Neurogene (NGNE) United States $0.281B 0.00
Atea Pharmaceuticals (AVIR) United States $0.277B 0.00
Foghorn Therapeutics (FHTX) United States $0.273B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.272B 12.22
Lifecore Biomedical (LFCR) United States $0.271B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.268B 0.00
DBV Technologies S.A (DBVT) France $0.268B 0.00
Crescent Biopharma (CBIO) United States $0.266B 0.00
Contineum Therapeutics (CTNM) United States $0.261B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.261B 0.00
Neumora Therapeutics (NMRA) United States $0.261B 0.00
Prima BioMed (IMMP) Australia $0.260B 0.00
Vor Biopharma (VOR) $0.260B 0.00
Codexis (CDXS) United States $0.259B 0.00
Alumis (ALMS) United States $0.257B 0.00
Puma Biotechnology (PBYI) United States $0.256B 5.19
Humacyte (HUMA) United States $0.247B 0.00
Annexon (ANNX) United States $0.241B 0.00
ScPharmaceuticals (SCPH) United States $0.238B 0.00
Editas Medicine (EDIT) United States $0.236B 0.00
Alpha Teknova (TKNO) United States $0.236B 0.00
Allogene Therapeutics (ALLO) United States $0.233B 0.00
Tvardi Therapeutics (TVRD) United States $0.231B 0.00
GENFIT S.A (GNFT) France $0.224B 0.00
Aardvark Therapeutics (AARD) United States $0.221B 0.00
Adherex Technologies (FENC) United States $0.220B 0.00
Alector (ALEC) United States $0.219B 0.00
CARGO Therapeutics (CRGX) United States $0.216B 0.00
Adocia (ADOCY) France $0.216B 0.00
Entrada Therapeutics (TRDA) United States $0.214B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.214B 0.00
Innate Pharma S.A (IPHA) France $0.213B 0.00
Sagimet Biosciences (SGMT) United States $0.212B 0.00
Monopar Therapeutics (MNPR) United States $0.207B 0.00
AC Immune (ACIU) Switzerland $0.206B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.204B 0.00
Voyager Therapeutics (VYGR) United States $0.197B 0.00
C4 Therapeutics (CCCC) United States $0.196B 0.00
EnGene Holdings (ENGN) Canada $0.194B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.194B 0.00
Tenaya Therapeutics (TNYA) United States $0.192B 0.00
Elicio Therapeutics (ELTX) United States $0.188B 0.00
Ventyx Biosciences (VTYX) United States $0.188B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.179B 0.00
SELLAS Life Sciences (SLS) United States $0.179B 0.00
Rapt Therapeutics (RAPT) United States $0.179B 0.00
Instil Bio (TIL) United States $0.172B 0.00
Tevogen Bio Holdings (TVGN) United States $0.171B 0.00
Sangamo Therapeutics (SGMO) United States $0.169B 0.00
Cellectis S.A (CLLS) France $0.166B 0.00
Actuate Therapeutics (ACTU) United States $0.165B 0.00
Caribou Biosciences (CRBU) United States $0.165B 0.00
Nkarta (NKTX) United States $0.163B 0.00
BioAge Labs (BIOA) United States $0.158B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.157B 0.00
Greenwich LifeSciences (GLSI) United States $0.156B 0.00
Nuvectis Pharma (NVCT) United States $0.156B 0.00
Cardiff Oncology (CRDF) United States $0.153B 0.00
BioHarvest Sciences (BHST) Canada $0.151B 0.00
Black Diamond Therapeutics (BDTX) United States $0.151B 11.52
TuHURA Biosciences (HURA) United States $0.150B 0.00
MaxCyte (MXCT) United States $0.149B 0.00
Theratechnologies (THTX) Canada $0.149B 0.00
Cabaletta Bio (CABA) United States $0.148B 0.00
Agenus (AGEN) United States $0.144B 0.00
Kyverna Therapeutics (KYTX) United States $0.143B 0.00
Seres Therapeutics (MCRB) United States $0.142B 0.00
Molecular Partners AG (MOLN) Switzerland $0.140B 0.00
Climb Bio (CLYM) United States $0.137B 0.00
IO Biotech (IOBT) Denmark $0.135B 0.00
Citius Oncology (CTOR) United States $0.133B 0.00
Fate Therapeutics (FATE) United States $0.131B 0.00
Alpha Cognition (ACOG) Canada $0.131B 0.00
Compugen (CGEN) Israel $0.130B 0.00
Genelux (GNLX) United States $0.130B 0.00
Scilex Holding (SCLX) United States $0.125B 0.00
Coherus Oncology (CHRS) United States $0.124B 0.00
Anika Therapeutics (ANIK) United States $0.124B 0.00
Cognition Therapeutics (CGTX) United States $0.123B 0.00
Immuneering (IMRX) United States $0.122B 0.00
Zura Bio (ZURA) United States $0.118B 0.00
Seer (SEER) United States $0.115B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.115B 0.00
BioStem Technologies (BSEM) $0.109B 5.68
Spero Therapeutics (SPRO) United States $0.104B 0.00
HilleVax (HLVX) United States $0.103B 0.00
Skye Bioscience (SKYE) United States $0.103B 0.00
23andMe Holding (MEHCQ) United States $0.102B 0.00
Biomea Fusion (BMEA) United States $0.102B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.102B 0.00
Connect Biopharma Holdings (CNTB) United States $0.101B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.100B 0.00
Oncolytics Biotech (ONCY) Canada $0.100B 0.00
Coya Therapeutics (COYA) United States $0.099B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.099B 0.00
XBiotech (XBIT) United States $0.098B 0.00
VistaGen Therapeutics (VTGN) United States $0.097B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.096B 0.00
TScan Therapeutics (TCRX) United States $0.095B 0.00
Alto Neuroscience (ANRO) United States $0.093B 0.00
Adagene (ADAG) China $0.092B 0.00
Pliant Therapeutics (PLRX) United States $0.090B 0.00
Immunic (IMUX) United States $0.090B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.089B 0.00
Oncobiologics (OTLK) United States $0.088B 0.00
Nautilus Biotechnology (NAUT) United States $0.087B 0.00
Quince Therapeutics (QNCX) United States $0.086B 0.00
Celularity (CELU) United States $0.086B 0.00
Entera Bio (ENTX) Israel $0.086B 0.00
OKYO Pharma (OKYO) $0.086B 0.00
CervoMed (CRVO) United States $0.085B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.084B 0.00
Elutia (ELUT) United States $0.083B 0.00
EXoZymes (EXOZ) United States $0.082B 0.00
Atara Biotherapeutics (ATRA) United States $0.081B 0.00
Whitehawk Therapeutics (WHWK) United States $0.078B 0.00
Forte Biosciences (FBRX) United States $0.077B 0.00
Sutro Biopharma (STRO) United States $0.073B 0.00
Inovio Pharmaceuticals (INO) United States $0.071B 0.00
BeyondSpring (BYSI) United States $0.071B 0.00
Applied Therapeutics (APLT) United States $0.070B 0.00
TELA Bio (TELA) United States $0.069B 0.00
ZIVO Bioscience (ZIVO) United States $0.069B 0.00
Invivyd (IVVD) United States $0.069B 0.00
Artiva Biotherapeutics (ARTV) United States $0.068B 0.00
Ovid Therapeutics (OVID) United States $0.067B 0.00
Opus Genetics (IRD) United States $0.067B 0.00
MiNK Therapeutics (INKT) United States $0.066B 0.00
Repare Therapeutics (RPTX) Canada $0.066B 0.00
Fortress Biotech (FBIO) United States $0.065B 0.00
INmune Bio (INMB) United States $0.064B 0.00
MediciNova (MNOV) United States $0.064B 0.00
Immix Biopharma (IMMX) United States $0.063B 0.00
Adlai Nortye (ANL) Cayman Islands $0.063B 0.00
Cue Biopharma (CUE) United States $0.063B 0.00
Genenta Science S.p.A (GNTA) Italy $0.062B 0.00
Earth Science Tech (ETST) United States $0.060B 0.00
Adverum Biotechnologies (ADVM) United States $0.060B 0.00
InflaRx (IFRX) Germany $0.059B 0.00
KALA BIO (KALA) United States $0.059B 0.00
Werewolf Therapeutics (HOWL) United States $0.058B 0.00
Precision BioSciences (DTIL) United States $0.057B 0.00
ImageneBio (IMA) United States $0.056B 0.00
Adicet Bio (ACET) United States $0.055B 0.00
PDS Biotechnology (PDSB) United States $0.055B 0.00
Aligos Therapeutics (ALGS) United States $0.054B 0.00
Quantum Biopharma (QNTM) Canada $0.052B 0.00
Annovis Bio (ANVS) United States $0.051B 0.00
VTv Therapeutics (VTVT) United States $0.050B 0.00
Shattuck Labs (STTK) United States $0.049B 0.00
ABVC BioPharma (ABVC) United States $0.048B 0.00
Lantern Pharma (LTRN) United States $0.048B 0.00
Kalaris Therapeutics (KLRS) United States $0.048B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.048B 0.00
ALX Oncology Holdings (ALXO) United States $0.048B 0.00
Grace Therapeutics (GRCE) Canada $0.046B 0.00
Clene (CLNN) United States $0.045B 0.00
Barinthus Biotherapeutics (BRNS) United States $0.044B 0.00
Alterity Therapeutics - (ATHE) Australia $0.044B 0.00
Generation Bio (GBIO) United States $0.043B 0.00
Equillium (EQ) United States $0.043B 0.00
Jasper Therapeutics (JSPR) United States $0.043B 0.00
Senti Biosciences (SNTI) United States $0.042B 0.00
PepGen (PEPG) United States $0.041B 0.00
Exicure (XCUR) United States $0.040B 0.00
Renovaro (RENB) United States $0.040B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.040B 0.00
Radiopharm Theranostics - (RADX) Australia $0.040B 0.00
Rani Therapeutics Holdings (RANI) United States $0.039B 0.00
CalciMedica (CALC) United States $0.039B 0.00
OnKure Therapeutics (OKUR) United States $0.037B 0.00
Mersana Therapeutics (MRSN) United States $0.036B 0.00
Pluri (PLUR) Israel $0.036B 0.00
Xilio Therapeutics (XLO) United States $0.035B 0.00
CAMP4 Therapeutics (CAMP) United States $0.034B 0.00
Estrella Immunopharma (ESLA) United States $0.034B 0.00
RenovoRx (RNXT) United States $0.034B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.032B 0.00
Clearside Biomedical (CLSD) United States $0.032B 0.00
AN2 Therapeutics (ANTX) United States $0.031B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.031B 0.00
BioXcel Therapeutics (BTAI) United States $0.030B 0.00
Dyadic (DYAI) United States $0.029B 0.00
Kezar Life Sciences (KZR) United States $0.028B 0.00
Cadrenal Therapeutics (CVKD) United States $0.028B 0.00
Tenax Therapeutics (TENX) United States $0.027B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.027B 0.00
Medicus Pharma (MDCX) United States $0.027B 0.00
Rein Therapeutics (RNTX) United States $0.026B 0.00
Boundless Bio (BOLD) United States $0.025B 0.00
FibroBiologics (FBLG) United States $0.025B 0.00
Rallybio (RLYB) United States $0.024B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.023B 0.00
Q32 Bio (QTTB) United States $0.022B 0.00
Passage Bio (PASG) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Femasys (FEMY) United States $0.022B 0.00
BioAtla (BCAB) United States $0.022B 0.00
SAB Biotherapeutics (SABS) United States $0.021B 0.00
Curis (CRIS) United States $0.020B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.020B 0.00
Cingulate (CING) United States $0.020B 0.00
Aytu BioPharma (AYTU) United States $0.020B 0.00
Promis Neurosciences (PMN) Canada $0.018B 0.00
Dare Bioscience (DARE) United States $0.018B 0.00
Moleculin Biotech (MBRX) United States $0.018B 0.00
Chemomab Therapeutics (CMMB) Israel $0.018B 0.00
LakeShore Biopharma (LSB) China $0.017B 0.00
X4 Pharmaceuticals (XFOR) United States $0.017B 0.00
Hoth Therapeutics (HOTH) United States $0.017B 0.00
Lexaria Bioscience (LEXX) Canada $0.017B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.016B 0.00
Synlogic (SYBX) United States $0.016B 0.00
Edesa Biotech (EDSA) Canada $0.016B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.016B 0.00
Soligenix (SNGX) United States $0.016B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.016B 0.00
Athira Pharma (ATHA) United States $0.016B 0.00
Cocrystal Pharma (COCP) United States $0.016B 0.00
MetaVia (MTVA) United States $0.015B 0.00
Imunon (IMNN) United States $0.015B 0.00
Abpro Holdings (ABP) United States $0.015B 0.00
IBio (IBIO) United States $0.014B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.014B 0.00
Intensity Therapeutics (INTS) United States $0.014B 0.00
NextCure (NXTC) United States $0.014B 0.00
Allarity Therapeutics (ALLR) United States $0.013B 0.00
Longeveron (LGVN) United States $0.013B 0.00
Gelteq (GELS) Australia $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
Beyond Air (XAIR) United States $0.012B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.012B 0.00
Leap Therapeutics (LPTX) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
GeoVax Labs (GOVX) United States $0.011B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
BioCardia (BCDA) United States $0.011B 0.00
IN8bio (INAB) United States $0.010B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.010B 0.00
Sensei Biotherapeutics (SNSE) United States $0.010B 0.00
Synaptogenix (TAOX) United States $0.010B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Bolt Biotherapeutics (BOLT) United States $0.009B 0.00
Advanced Biomed (ADVB) United States $0.009B 0.00
Portage Biotech (PRTG) $0.008B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.008B 0.00
COSCIENS Biopharma (CSCI) Canada $0.008B 0.00
Mainz Biomed (MYNZ) Germany $0.008B 0.00
Adial Pharmaceuticals (ADIL) United States $0.008B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
BioAffinity Technologies (BIAF) United States $0.008B 0.00
Novogen (KZIA) Australia $0.007B 0.00
Mustang Bio (MBIO) United States $0.007B 0.00
Artelo Biosciences (ARTL) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
Sunshine Biopharma (SBFM) United States $0.006B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
Polyrizon (PLRZ) Israel $0.006B 0.00
Apollomics (APLM) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Purple Biotech (PPBT) Israel $0.006B 0.00
Psyence Biomedical (PBM) Canada $0.006B 0.00
GENPREX (GNPX) United States $0.006B 0.00
Tharimmune (THAR) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
HCW Biologics (HCWB) United States $0.005B 0.00
BRIACELL THERAP (BCTX) Canada $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
Palisade Bio (PALI) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.004B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
GRI Bio (GRI) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
CNS Pharmaceuticals (CNSP) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Onconetix (ONCO) United States $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Propanc Biopharma Inc (PPCB) Australia $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00